EP 1753433 A1 20070221 - PHARMACEUTICAL COMPOSITIONS COMPRISING NEP-INHIBITORS, INHIBITORS OF THE ENDOGENOUS ENDOTHELIN PRODUCING SYSTEM AND PDE V INHIBITORS
Title (en)
PHARMACEUTICAL COMPOSITIONS COMPRISING NEP-INHIBITORS, INHIBITORS OF THE ENDOGENOUS ENDOTHELIN PRODUCING SYSTEM AND PDE V INHIBITORS
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT NEP-HEMMERN; HEMMERN DES ENDOGENEN ENDOTHELIN-PRODUZIERENDEN SYSTEMS UND PDEV-HEMMERN
Title (fr)
COMPOSITIONS PHARMACEUTIQUES RENFERMANT DES INHIBITEURS DE L'ENDOPEPTIDASE NEUTRE (NEP), DES INHIBITEURS DU SYSTEME DE PRODUCTION DE L'ENDOTHELINE ENDOGENE ET DES INHIBITEURS DE LA PHOSPHODIESTERASE 5 (PDE V)
Publication
Application
Priority
- EP 2005052158 W 20050512
- US 57082904 P 20040514
- EP 04102119 A 20040514
- EP 05747723 A 20050512
Abstract (en)
[origin: WO2005112939A1] The present invention relates to the novel medicinal use of dually acting compounds capable of inhibiting neutral endopeptidase (= NEP) and human soluble endopeptidase (= hSEP) in the prophylaxis and/or treatment of sexual dysfunction in mammals and humans.
IPC 8 full level
A61K 31/33 (2006.01); A61K 31/4985 (2006.01); A61K 31/519 (2006.01); A61K 31/55 (2006.01); A61P 15/00 (2006.01); A61P 15/10 (2006.01)
CPC (source: EP)
A61K 31/33 (2013.01); A61K 31/4985 (2013.01); A61K 31/519 (2013.01); A61K 31/55 (2013.01); A61P 15/00 (2017.12); A61P 15/10 (2017.12)
Citation (search report)
See references of WO 2005112940A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005112939 A1 20051201; EP 1753432 A1 20070221; EP 1753433 A1 20070221; WO 2005112940 A1 20051201
DOCDB simple family (application)
EP 2005052156 W 20050512; EP 05743154 A 20050512; EP 05747723 A 20050512; EP 2005052158 W 20050512